Vivos Inc. (OTCMKTS:RDGL) Short Interest Update

Vivos Inc. (OTCMKTS:RDGL) was the recipient of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 75,000 shares, a decrease of 19.9% from the February 28th total of 93,600 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 822,100 shares, the days-to-cover ratio is presently 0.1 days.

Vivos Trading Up 0.1 %

RDGL stock traded up $0.00 during trading on Tuesday, hitting $0.12. 432,421 shares of the stock traded hands, compared to its average volume of 1,011,757. The stock has a market cap of $55.31 million, a price-to-earnings ratio of -12.20 and a beta of 0.89. Vivos has a one year low of $0.06 and a one year high of $0.26. The company has a 50 day simple moving average of $0.13 and a 200 day simple moving average of $0.13.

Vivos Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.